FDA Inspection 1308792 — Jubilant DraxImage Radiopharmacies
The FDA completed an inspection of Jubilant DraxImage Radiopharmacies on March 23, 2026 in Mobile, AL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 23, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mobile, AL (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 17753 | 21 CFR 212.30(c) | Contact surfaces |
| 17764 | 21 CFR 212.20(e) | Written QA procedures established, followed |